Close Menu
USAHITMAN Conspiracy News
    Facebook X (Twitter) Instagram
    USAHITMAN Conspiracy NewsUSAHITMAN Conspiracy News
    • Home
    • Featured News
      Featured

      Prince Warned Of 9/11 Attacks In 1998

      9/11 May 7, 2016
      Recent

      Hunter Biden filmed himself smoking crack behind the wheel, driving at 172mph on way to Vegas: photos

      July 2, 2023

      King Charles, Bill Gates Foundation and The OceanGate Missing Submarine – How its connected

      June 22, 2023

      Why Is WEF & Bill Gates-Funded APEEL ON Organic Produce?

      June 18, 2023
    • Conspiracy News
      1. 911 Conspiracy
      2. Big Brother
      3. Police State
      4. NWO
      5. UFOs & ETs
      6. Conspiracy or Not
      7. Freemasonry
      8. Chemtrails
      9. HAARP News
      10. The Unknown
      11. Terrorism
      12. Lies & Hoaxes
      Featured

      Candidate Le Pen’s Political Ad Regarding France from the Year 2011

      Conspiracy or Not July 3, 2023
      Recent

      Candidate Le Pen’s Political Ad Regarding France from the Year 2011

      July 3, 2023

      Justice Department: Misconduct by federal jail guards led to Jeffrey Epstein’s suicide

      June 28, 2023

      The 4th Dimension and the Birth of the Jungle Gym

      June 27, 2023
    • Interesting News
      1. Covid
      2. Deaths
      3. Food & Health News
      4. Economy & Money
      5. Restrictions
      6. Bitcoin News
      7. Our Second Amendment
      8. Science & Space
      9. Much More News
      Featured

      U.S. Navy says it can convert seawater into fuel

      Interesting News April 8, 2014
      Recent

      George Soros’ foundation lays off 40% of workforce after billionaire investor’s son takes over

      July 1, 2023

      Supreme Court rejects affirmative action at colleges as unconstitutional

      June 30, 2023

      Prosecutor Reportedly Told Six Witnesses He Was Not Permitted To Charge Hunter Biden

      June 28, 2023
    • Archived Years
      • 2010 Articles
      • 2011 Articles
      • 2012 Articles
    USAHITMAN Conspiracy News
    Home»Interesting News»All Patents held by Anthony Fauci

    All Patents held by Anthony Fauci

    November 27, 202111 Mins Read
    Facebook Twitter Reddit Telegram Email

    Anthony S. Fauci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).


    • Use of antagonists of the interaction between HIV GP120 and ?4?7 integrin Patent number: 9896509 – Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
    • Type: Grant Filed: August 3, 2016Date of Patent: February 20, 2018 Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

    • USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN Publication number: 20160333097 – Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
    • Type: Application Filed: August 3, 2016Publication date: November 17, 2016 Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Serv Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

    • Use of antagonists of the interaction between HIV GP120 and ?4?7 integrin Patent number: 9441041 – Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.
    • Type: Grant – Filed: September 21, 2015 – Date of Patent: September 13, 2016 – Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services – Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

    • USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN Publication number: 20160075786 – Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist, thereby treating the HIV infection. In several examples, the ?4 integrin antagonist is a monoclonal antibody that specifically binds to a ?4, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and ?4 integrin, such as a ?4?1 or ?4?7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV
    • Type: Application – Filed: September 21, 2015 – Publication date: March 17, 2016 – Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Services – Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

    • IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION Publication number: 20090285815 – Abstract: Nucleic acids encoding recombinant CD4-fusion proteins are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C terminus of the heavy chain of an IgA antibody or a tailpiece from a C terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
    • Type: Application – Filed: March 21, 2008 – Publication date: November 19, 2009 – Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

    • Fusion protein including of CD4 Patent number: 7368114 – Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion or the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody ara tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4 fusion proteins.
    • Type: Grant – Filed: October 24, 2002 – Date of Patent: May 6, 2008 – Assignee: The United States of America as represented by the Department of Health and Human Services – Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

    • HIV related peptides Patent number: 6911527 – Abstract: This invention is the discovery of novel specific epitopes and antibodies associated with long term survival of HIV-1 infections. These epitopes and antibodies have use in preparing vaccines for preventing HIV-1 infection or for controlling progression to AIDS.
    • Type: Grant – Filed: January 7, 2000 – Date of Patent: June 28, 2005 – Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services – Inventors: Giuseppe Scala, Xueni Chen, Oren J. Cohen, Anthony S. Fauci

    • Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 Publication number: 20040265306 – Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody or a tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
    • Type: Application – Filed: July 27, 2004 – Publication date: December 30, 2004 – Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

    • Immunologic enhancement with intermittent interleukin-2 therapy Publication number: 20030180254 – Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
    • Type: Application – Filed: January 23, 2003 – Publication date: September 25, 2003 – Applicant: The Govt. of the USA as represented by the Secretary of the Dept. of Health & Human Services – Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

    • Immunologic enhancement with intermittent interleukin-2 therapy Patent number: 6548055 – Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
    • Type: Grant – Filed: August 9, 2000 – Date of Patent: April 15, 2003 – Assignee: The United States of America as represented by the Department of Health and Human Services – Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

    • Immunologic enhancement with intermittent interleukin-2 therapy Patent number: 6190656 – Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
    • Type: Grant – Filed: September 2, 1997 – Date of Patent: February 20, 2001 – Assignee: The United States of America as represented by the Department of Health and Human Services – Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

    • Immunologic enhancement with intermittent interleukin-2 therapy – Patent number: 5696079 – Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value. This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
    • Type: Grant – Filed: May 26, 1995 – Date of Patent: December 9, 1997 –Assignee: The United States of America as represented by the Department of Health and Human Services –Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci
    Anthony Fauci Coronavirus Covid19 HIV NIH Patents Research Science
    Share. Facebook Twitter Pinterest Email Reddit

    Related Posts

    George Soros’ foundation lays off 40% of workforce after billionaire investor’s son takes over

    July 1, 2023

    Supreme Court rejects affirmative action at colleges as unconstitutional

    June 30, 2023

    Wuhan researcher claims China engineered COVID-19 as a ‘bioweapon’

    June 28, 2023

    Candidate Le Pen’s Political Ad Regarding France from the Year 2011

    July 3, 2023

    Vaccine billionaire’s 3000 per cent gain with surprise bet

    July 3, 2023

    Hunter Biden filmed himself smoking crack behind the wheel, driving at 172mph on way to Vegas: photos

    July 2, 2023

    Millions of Your Taxpayer Dollars Are Going to Fund Foreign Pride Parades and Drag Shows

    July 2, 2023
    Categories
    • 9/11 (108)
    • Big Brother (635)
    • Conspiracy or Not (567)
    • Covid (270)
    • Deaths (71)
    • Economy & Money (953)
    • Featured News (377)
    • Food & Health News (1,146)
    • Fukushima (82)
    • Interesting News (1,956)
    • Lies & Hoaxes (112)
    • More News (2,399)
    • NWO (385)
    • Police State (628)
    • Politics (333)
    • Predictions and Prophecies (43)
    • Random News (2,487)
    • Restrictions (152)
    • Science & Space (953)
    • Second Amendment (129)
    • Secret Societies (112)
    • Survival (67)
    • Terrorism (595)
    • The Unknown (666)
    • UFOs & ETs (388)
    • Vaccine News (237)
    • War News (878)
    • Weather Manipulation (34)
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.